Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
GTB-3650
i
Other names:
GTB-3650, OXS-C3550, Anti-CD16-IL-15-anti-CD33 TriKE
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
GT Biopharma
Drug class:
IL-15R stimulant, CD16 agonist, CD33 inhibitor
Related drugs:
‹
FT596 (2)
SAR445710 (2)
ACTM-838 (0)
AGAR T cells (0)
FT538 (0)
GT-00A x IL15 (0)
GTB-3550 TRIKE (0)
HCW9218 (0)
NIZ985 (0)
PF-07209960 (0)
RPTR-147:1 (0)
RTX-240 (0)
VG161 (0)
VG201 (0)
iC9.GD2.CAR.IL-15 T-cells (0)
FT516 (1)
GTB-5550 (1)
IPH6101 (1)
NY-303 (0)
NY-338 (0)
AMV564 (2)
BI 836858 (0)
CD33/CLL1 dual CAR-NK cell (0)
GEM333 (0)
IBR733 (0)
JNJ-67571244 (0)
MP0533 (0)
QN-023a (0)
lintuzumab (0)
AMG 330 (0)
AMG 673 (0)
huCD33-BsAb (0)
FT596 (2)
SAR445710 (2)
ACTM-838 (0)
AGAR T cells (0)
FT538 (0)
GT-00A x IL15 (0)
GTB-3550 TRIKE (0)
HCW9218 (0)
NIZ985 (0)
PF-07209960 (0)
RPTR-147:1 (0)
RTX-240 (0)
VG161 (0)
VG201 (0)
iC9.GD2.CAR.IL-15 T-cells (0)
FT516 (1)
GTB-5550 (1)
IPH6101 (1)
NY-303 (0)
NY-338 (0)
AMV564 (2)
BI 836858 (0)
CD33/CLL1 dual CAR-NK cell (0)
GEM333 (0)
IBR733 (0)
JNJ-67571244 (0)
MP0533 (0)
QN-023a (0)
lintuzumab (0)
AMG 330 (0)
AMG 673 (0)
huCD33-BsAb (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.